ReviewPharmaceutics2026

Emerging Precision Therapeutic Strategies in Pancreatic Ductal Adenocarcinoma: KRAS Targeting, DDR Vulnerabilities, Immune Redirection, and Tumor Microenvironment Remodeling.

Jun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.